Delivery Order SPE2DB22D3301-SPE2DB24FY2HY
Award Date 3/11/24
Potential Completion Date 3/12/24
Potential Value $9.5K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,196.53, is for the delivery of 4,564,460,309 units of doxepin hydrochloride 3 mg tablets. The contract has an ultimate completion date of May 2, 2024 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The delivery order is for the supply of 4,563,489,997 units of 3 milligram Doxepin HCL tablets in 30-count packages, with a potential value of $6,537.78 and a completion date of January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $12,520.40 firm fixed-price contract is for the provision of Doxepin HCl 6 mg tablets and has a performance period through February 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of doxepin hydrochloride 3 mg tablets. The contract has a ceiling value of $7,530.03 and runs through June 11, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,336.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,296,828 units of Doxepin HCL 3 mg tablets. This fixed-price delivery order has an ultimate completion date of April 17, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,921.83 Firm Fixed Price contract is for the supply of Doxepin HCL 6 mg tablets. The contract has an ultimate completion date of December 13, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical covering a broad range of...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,963.49, is for the delivery of Doxepin HCL 3 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 18, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,834.02 firm fixed-price delivery order contract is for the supply of DOXEPIN HCL 3 MG TABLET 30S, with a performance period through February 14, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Doxepin HCL 3 mg tablets in 30-count packages, with a ceiling value of $1,751.01 and a completion date of March 29, 2024. The contract is a firm fixed price delivery order, which is part of a larger indefinite delivery contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,561.98 contract is for the delivery of Doxepin HCL 3 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of May 23, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...